These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35622077)

  • 1. Factors Associated with Intention to Initiate Pre-exposure Prophylaxis in Cisgender Women at High Behavioral Risk for HIV in Washington, D.C.
    Scott RK; Hull SJ; Huang JC; Coleman M; Ye P; Lotke P; Beverley J; Moriarty P; Balaji D; Ward A; Holiday J; Brant AR; Cameron M; Elion R; Visconti A
    Arch Sex Behav; 2022 Jul; 51(5):2613-2624. PubMed ID: 35622077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intention to Initiate HIV Pre-exposure Prophylaxis Among Cisgender Women in a High HIV Prevalence U.S. City.
    Scott RK; Hull SJ; Huang JC; Ye PP; Lotke P; Beverley J; Moriarty P; Balaji D; Ward A; Holiday J; Brant AR; Elion R; Visconti AJ; Coleman M
    Womens Health Issues; 2023; 33(5):541-550. PubMed ID: 37479630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related factors associated with intention to initiate pre-exposure prophylaxis among cisgender women in Washington D.C.
    Zack JL; Hull SJ; Coleman ME; Ye PP; Lotke PS; Visconti A; Beverley J; Brant A; Moriarty P; Scott RK
    Ther Adv Infect Dis; 2024; 11():20499361241252351. PubMed ID: 38751758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness, acceptability, and intention to initiate HIV pre-exposure prophylaxis among pregnant women.
    Scott RK; Hull SJ; Richards RC; Klemmer K; Salmoran F; Huang JC
    AIDS Care; 2022 Feb; 34(2):201-213. PubMed ID: 33874801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "PrEP"ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women.
    Pasipanodya EC; Stockman J; Phuntsog T; Morris S; Psaros C; Landovitz R; Amico KR; Moore DJ; Blumenthal J
    BMC Womens Health; 2021 May; 21(1):220. PubMed ID: 34034719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding Influences on Intention to Use Pre-exposure Prophylaxis (PrEP) Among African American Young Adults.
    Ayangeakaa SD; Kerr J; Combs R; Harris L; Sears J; Parker K; Sterrett-Hong E
    J Racial Ethn Health Disparities; 2023 Apr; 10(2):899-910. PubMed ID: 35290648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Let Me Prep You to PREP Me: Amplifying the Voices of Black Women and Their Providers to Consider PrEP as an HIV Prevention Option.
    Chandler R; Guillaume D; Wells J; Hernandez N
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV risk perception, pre-exposure prophylaxis (PrEP) awareness, and PrEP initiation intention among women who use drugs.
    Darlington CK; Lipsky RK; Teitelman AM; Koblin BA; Davis A; Walcott M; Compton PA; Tieu HV
    J Subst Use Addict Treat; 2023 Sep; 152():209119. PubMed ID: 37451517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness and Intent to Use Pre-exposure Prophylaxis (PrEP) Among African American Women in a Family Planning Clinic.
    Johnson AK; Fletcher FE; Ott E; Wishart M; Friedman EE; Terlikowski J; Haider S
    J Racial Ethn Health Disparities; 2020 Jun; 7(3):550-554. PubMed ID: 31848943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ameliorating Racial Disparities in HIV Prevention via a Nurse-Led, AI-Enhanced Program for Pre-Exposure Prophylaxis Utilization Among Black Cisgender Women: Protocol for a Mixed Methods Study.
    Zhang C; Wharton M; Liu Y
    JMIR Res Protoc; 2024 Aug; 13():e59975. PubMed ID: 39137028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Retention in the HIV Pre-Exposure Prophylaxis Cascade Among Cisgender Women.
    Burns JA; Hull SJ; Inuwa A; Moriarty P; Scott RK
    AIDS Patient Care STDS; 2023 Apr; 37(4):205-211. PubMed ID: 36961388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beliefs Associated with Intention to Use PrEP Among Cisgender U.S. Women at Elevated HIV Risk.
    Teitelman AM; Chittamuru D; Koblin BA; Davis A; Brawner BM; Fiore D; Broomes T; Ortiz G; Lucy D; Tieu HV
    Arch Sex Behav; 2020 Aug; 49(6):2213-2221. PubMed ID: 32270399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Psychosocial Determinants of PrEP Uptake Among Cisgender Women Experiencing Heightened HIV Risk: Implications for Multi-Level Communication Intervention.
    Hull SJ; Duan X; Brant AR; Peng Ye P; Lotke PS; Huang JC; Coleman ME; Nalls P; Scott RK
    Health Commun; 2023 Dec; 38(14):3264-3275. PubMed ID: 36398676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Young Transgender Women's Attitudes Toward HIV Pre-exposure Prophylaxis.
    Wood SM; Lee S; Barg FK; Castillo M; Dowshen N
    J Adolesc Health; 2017 May; 60(5):549-555. PubMed ID: 28132744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "PrEP's just to secure you like insurance": a qualitative study on HIV pre-exposure prophylaxis (PrEP) adherence and retention among black cisgender women in Mississippi.
    Willie TC; Monger M; Nunn A; Kershaw T; Stockman JK; Mayer KH; Chan PA; Adimora AA; Mena LA; Knight D; Philllips KA; Baral SD
    BMC Infect Dis; 2021 Oct; 21(1):1102. PubMed ID: 34702165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Implementation Strategies to Enhance HIV Pre-Exposure Prophylaxis Uptake Among Black Cisgender Women in New Orleans, Louisiana.
    Clement ME; Perry B; McKenna K; Beckford J; Davenport T; Murray E; Magee V; Bickham JN; Siren J; Smith A; Lillis R; Corneli A
    AIDS Patient Care STDS; 2024 Mar; 38(3):144-150. PubMed ID: 38471093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Moderating Effects of HIV Relevant Factors on the Relationship Between Intimate Partner Violence and Intention to Start HIV Pre-exposure Prophylaxis (PrEP) Among Cisgender Women.
    Keddem S; Frye V; Davis A; Koblin BA; Tieu HV; Lipsky RK; Nandi V; Teitelman AM
    Arch Sex Behav; 2024 Apr; 53(4):1531-1539. PubMed ID: 38366311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where's the "Everyday Black Woman"? An intersectional qualitative analysis of Black Women's decision-making regarding HIV pre-exposure prophylaxis (PrEP) in Mississippi.
    Willie TC; Knight D; Baral SD; Chan PA; Kershaw T; Mayer KH; Stockman JK; Adimora AA; Monger M; Mena LA; Philllips KA; Nunn A
    BMC Public Health; 2022 Aug; 22(1):1604. PubMed ID: 35999528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an Electronic Algorithm for Identifying Cisgender Female Pre-Exposure Prophylaxis Candidates.
    Ridgway JP; Friedman EE; Bender A; Schmitt J; Cronin M; Brown RN; Johnson AK; Hirschhorn LR
    AIDS Patient Care STDS; 2021 Jan; 35(1):5-8. PubMed ID: 33400588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drawing from the Theory of Planned Behaviour to examine pre-exposure prophylaxis uptake intentions among heterosexuals in high HIV prevalence neighbourhoods in Philadelphia, Pennsylvania, USA: an observational study.
    Roth A; Felsher M; Tran N; Bellamy S; Martinez-Donate A; Krakower D; Szep Z
    Sex Health; 2019 Jun; 16(3):218-224. PubMed ID: 31079596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.